We know antibiotics in the #environment are a driver for #AMR
One intervention to reduce risk in this sector could be formal regulation to control #antibiotic levels in #manufacturing discharge But how viable are these measures? 🧵/1
One intervention to reduce risk in this sector could be formal regulation to control #antibiotic levels in #manufacturing discharge But how viable are these measures? 🧵/1
Antibiotic supply chains are complex & opaque🕵️ This makes it hard for #policymakers to design and implement effective supply chain regulation that reduces #AMR risk but avoids unintended consequences on medicine affordability and availability /2
A new @Wellcome_AMR report attempts to address these ongoing questions through:
- mapping of antibiotic supply chains 🗺️
- analysing likely supply chain & economic impact of regulatory options 💹
- recommending next steps for supply chain sensitive regulatory approaches 🤝
/3
- mapping of antibiotic supply chains 🗺️
- analysing likely supply chain & economic impact of regulatory options 💹
- recommending next steps for supply chain sensitive regulatory approaches 🤝
/3
Findings suggest measures to limit #antibiotic discharges are viable 👍
But to #StopSuperbugs policies must be carefully constructed, especially for supply chains with lower #resilience - thinking about:
- what measures 📏
- how to implement 🔧
- who leads ✋
/4
But to #StopSuperbugs policies must be carefully constructed, especially for supply chains with lower #resilience - thinking about:
- what measures 📏
- how to implement 🔧
- who leads ✋
/4
Read more from @SianLWilliams92 on the key findings here 👉 linkedin.com/pulse/antibiot…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
